X
GO
Statement on the Brazil Variant (P.1)

Statement on the Brazil Variant (P.1)

Given the nature of the virus (SARS-CoV-2) that causes COVID-19, variants are likely to emerge, and several have emerged all over the world.

Variants are a natural part of viral infection and replication. In this regard, the emergence of SARS-CoV-2 variants that cause COVID-19, such as Brazil, UK and South African  variants, is normal and expected. Some variants have been reported to be more virulent and transmissible.

With regard to the Brazil variant (P.1), a recent study conducted by AstraZeneca suggests that the vaccine will work against the P.1 variant from Brazil. The Brazilian regulatory authorities have assessed it and are so far satisfied by the results. So much so, that the Brazilian government has since approved the AstraZeneca vaccine for use in its population where the P.1 variant is widespread and has ordered more than 200 million doses of Astra Zeneca.

CARPHA is awaiting the publication of the full study by AstraZeneca to provide more complete information on the degree of efficacy.

Researchers are also working to learn more about the ease of spread and transmission of the variants, whether they could cause more severe illness, and whether currently authorised vaccines will fully protect us against them.  

CARPHA continues to monitor current research on vaccines, variants and the modifications being made to current vaccines and their effectiveness as a consequence of the variants.

We are also diligently working with The University of the West Indies, St Augustine on genome sequencing and we are monitoring the variants in the Region.  

There was a concern about the P.1 variant being detected in one country.  However, the situation was contained, and the individual was not allowed to leave the vessel.

CARPHA also reported the detection of a variant in the Caribbean that is related to the P.1 variant, but not quite the same. This new variant may carry changes which will require additional research to determine their effects on transmissibility and efficacy of vaccines. 

We are assured by the scientific research of the results of reduced disease in countries which have vaccinated large percentages of their populations.

CARPHA encourages the population of our Region to be vaccinated.

Statement on the Brazil Variant (P.1) accompanying video clip https://youtu.be/WgN6ao3Ftto

Thank you.

 

 

Tags

Categories

News, New at CARPHA

Share

Rating

0 ( 0 reviews)

Post a Comment

  • Recent
  • Popular
  • Tag
  • CARPHA Encourages Persons to Know their Blood Pressure

    CARPHA Encourages Persons to Know their Blood Pressure

    0 Comments

    Port-of-Spain, Trinidad and Tobago, May 16, 2014: The Caribbean Public Health Agency (CARPHA) is calling on persons to know their blood pressure, strive to keep it healthy or lower it. This is in keep...
  • CARPHA and CTO Launch Tourism and Health Programme

    0 Comments

    CARPHA and CTO successfully launched the regional tourism and health programme and conducted an awareness and discussion workshop on Friday May 2, 2014 in Aruba. The keynote address was given by the M...
  • CARPHA’s new Chairman of the Board

    CARPHA’s new Chairman of the Board

    0 Comments

    Port-of-Spain, Trinidad and Tobago, October 02, 2013: The Caribbean Public Health Agency (CARPHA) is pleased to announce the appointment of the Honourable Colin Riley, Minister of Health of Montserrat...
  • Saint Lucia Joins Regional Project to Build Public Health Capacity

    Saint Lucia Joins Regional Project to Build Public Health Capacity

    0 Comments

    Castries, Saint Lucia, September 04, 2014. The Ministry of Health, Wellness, Human Services and Gender Relations, in collaboration with the Caribbean Public Health Agency (CARPHA), is launching the Ca...
  • New CARPHA lab to help region respond to health threats

    New CARPHA lab to help region respond to health threats

    1 Comments

    The Caribbean Public Health Agency (CARPHA) moved today one step forward in its mission to provide strategic direction in analyzing, defining and responding to public health priorities of CARICOM, in ...
  • GRANT WRITING WORKSHOP

    0 Comments

    The Center for Global Health of the National Cancer Institute (NCI), National Institutes of Health (NIH) in the U.S., in collaboration with the Caribbean Public Health Agency (CARPHA), St. George's Un...
  • CR-FELTP Trains New Mentors in Jamaica

    CR-FELTP Trains New Mentors in Jamaica

    0 Comments

    Caribbean Regional Field Epidemiology and Laboratory Training Programme (CR-FELTP) Trains New Mentors in Jamaica The Caribbean Public Health Agency (CARPHA) hosted a four-day workshop in Kingston, Jam...
  • Risk of Ebola in the Caribbean

    Risk of Ebola in the Caribbean "Low"

    0 Comments

    Port-of-Spain, Trinidad and Tobago, August 06, 2014: The Caribbean Public Health Agency (CARPHA) says the risk of the Ebola Virus Disease (EVD) being imported to the Caribbean is low. Executive Direct...
  • Risk Communication Training to Help Senior Health Officials Better Manage Health Threats

    0 Comments

    Risk Communication Training to Help Senior Health Officials Better Manage Health Threats Providenciales, Turks and Caicos, June 19, 2016: "Risk communication is an important tool in managing health th...
  • Influenza Activity in the Caribbean

    Influenza Activity in the Caribbean

    2 Comments

    Port of Spain, Trinidad and Tobago, September 26, 2013. The Caribbean, like other regions in the Americas, experiences seasonal influenza activity. Improved health monitoring by Ministries of Health i...